Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
GSK189075 is intended for use as a single treatment or in combination with other treatments
for tye 2 diabetes mellitus (T2DM). Metformin is widely used in Europe and the USA for the
treatment of T2DM. This study will evaluate the effect of GSK189075 on metformin levels in
the blood in T2DM subjects. The rationale is to look for any safety problems that may result
when the 2 drugs are given together.